Postmenopausal osteoporosis
Conditions
Interventions
Rehabilitation magnetic therapy group:Magnetic therapy + medicine
Drug control group:Drug
Acupuncture group:Medicine + acupuncture
Sponsors
Affiliated Hospital of Yunnan University
Eligibility
Sex/Gender
Female
Age
46 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. All cases met the above diagnostic criteria of TCM and Western medicine; 2.46 years old = age =75 years old, and more than 1 year of natural menopause; 3. Patients who were able to receive complete 6 months of medication (calcium carbonate D3 and alendronate sodium), PEMF and "holistic adjustment acupuncture (including warm acupuncture, seven-star acupuncture, cupping and cupping)", and did not receive other medications or other related interventions for postmenopausal osteoporosis in the last 6 months; 4. Voluntarily participate in the study and sign the informed consent for treatment. (Note: Only those who meet the above four criteria can be included in the study)
Exclusion criteria
Exclusion criteria: 1. Women with abnormal anatomical structure of the lumbar spine (such as severe scoliosis) were excluded; 2. Exclude endocrine disorders related to secondary osteoporosis (such as diabetes, hyperthyroidism, hypothyroidism, thyroid cysts, etc.); 3. Removal of uterus or ovary; 4. Concomitant diseases such as chondrosis, rheumatoid arthritis or other diseases that affect the dynamic balance of bone metabolism; 5. Have taken drugs that can interfere with bone metabolism (such as glucocorticoid, calcitonin, estrogen, etc.) in the last 6 months; 6. Patients with serious underlying diseases and mental diseases; 7. Drug or alcohol abuse; 8. Female patients with mental disorders who cannot comply with the treatment research program; 9. Subjects who are participating in other exclusion criteria in Paragraph 1 should be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bone mineral density;Amino terminal propeptide of serum type ? procollagen;Tartrate-resistant acid phosphatase;Bone-specific alkaline phosphatase;Bone resorption marker serum ß -i collagen carboxy-terminal peptide; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome score;visual analogue scale;Follicle-stimulating hormone;estradiol;Quality of Life Scale score; | — |
Countries
ch
Contacts
Public ContactLai Mingxing
Outcome results
None listed